Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy DOI Creative Commons
Weiqin Jiang,

Yinjun He,

Wenguang He

et al.

Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 11

Published: Feb. 2, 2021

Tumor-specific CD8+T cells are exposed to persistent antigenic stimulation which induces a dysfunctional state called "exhaustion." Though functioning limit damage caused by immune response, T cell exhaustion leads attenuated effector function whereby cytotoxic fail control tumor progression in the late stage. This pathway is dynamic process from activation "progenitor exhaustion" through "terminally with distinct properties. With rapid development of immunotherapy via enhancing function, new studies dissecting mechanisms and identifying specific biomarkers differentiation during exhaustion. Further, although checkpoint inhibitors (ICIs) have achieved great success clinical practice, most patients still show limited efficacy ICIs. The expansion progenitor exhausted explained ICIs while depletion pool transient terminally accounted for failure monotherapy context exorbitant burden. Thus, combination strategies urgent be utilized based on reduction burden or pool. In this review, we aim introduce concept homeostasis activated status microenvironment, present recent findings implications therapy.

Language: Английский

Clonal replacement of tumor-specific T cells following PD-1 blockade DOI
Kathryn E. Yost, Ansuman T. Satpathy, Daniel K. Wells

et al.

Nature Medicine, Journal Year: 2019, Volume and Issue: 25(8), P. 1251 - 1259

Published: July 29, 2019

Language: Английский

Citations

1194

Defining ‘T cell exhaustion’ DOI
Christian U. Blank, W. Nicholas Haining, Werner Held

et al.

Nature reviews. Immunology, Journal Year: 2019, Volume and Issue: 19(11), P. 665 - 674

Published: Sept. 30, 2019

Language: Английский

Citations

1194

CD8+ T cell states in human cancer: insights from single-cell analysis DOI
Anne M. van der Leun, Daniela S. Thommen, Ton N. Schumacher

et al.

Nature reviews. Cancer, Journal Year: 2020, Volume and Issue: 20(4), P. 218 - 232

Published: Feb. 5, 2020

Language: Английский

Citations

1139

TIM3 comes of age as an inhibitory receptor DOI Open Access
Yochai Wolf, Ana C. Anderson, Vijay K. Kuchroo

et al.

Nature reviews. Immunology, Journal Year: 2019, Volume and Issue: 20(3), P. 173 - 185

Published: Nov. 1, 2019

Language: Английский

Citations

749

Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms DOI Creative Commons
Jean‐Christophe Beltra, Sasikanth Manne, Mohamed S. Abdel-Hakeem

et al.

Immunity, Journal Year: 2020, Volume and Issue: 52(5), P. 825 - 841.e8

Published: May 1, 2020

Language: Английский

Citations

746

CD8+ T cell differentiation and dysfunction in cancer DOI
Mary Philip, Andrea Schietinger

Nature reviews. Immunology, Journal Year: 2021, Volume and Issue: 22(4), P. 209 - 223

Published: July 12, 2021

Language: Английский

Citations

695

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells DOI

Caroline S. Jansen,

Nataliya Prokhnevska, Viraj A. Master

et al.

Nature, Journal Year: 2019, Volume and Issue: 576(7787), P. 465 - 470

Published: Dec. 11, 2019

Language: Английский

Citations

664

Tertiary lymphoid structures in cancer DOI
Ton N. Schumacher, Daniela S. Thommen

Science, Journal Year: 2022, Volume and Issue: 375(6576)

Published: Jan. 6, 2022

Ectopic lymphoid aggregates, termed tertiary structures (TLSs), are formed in numerous cancer types, and, with few exceptions, their presence is associated superior prognosis and response to immunotherapy. In spite of presumed importance, the triggers that lead TLS formation tissue contribution these intratumoral immune responses remain incompletely understood. Here, we discuss present knowledge on TLSs cancer, focusing (i) drivers formation, (ii) function antitumor response, (iii) potential as therapeutic targets human cancers.

Language: Английский

Citations

663

CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer DOI Creative Commons
Ryan Zander, David Schauder, Gang Xin

et al.

Immunity, Journal Year: 2019, Volume and Issue: 51(6), P. 1028 - 1042.e4

Published: Dec. 1, 2019

Although CD4+ T cell "help" is crucial to sustain antiviral immunity, the mechanisms by which cells regulate CD8+ differentiation during chronic infection remain elusive. Here, using single-cell RNA sequencing, we show that responding were more heterogeneous than previously appreciated. Importantly, our findings uncovered formation of a CX3CR1-expressing subset exhibited potent cytolytic function and was required for viral control. Notably, data further demonstrate this cytotoxic critically dependent on help via interleukin-21 (IL-21) exploitation developmental pathway could be used therapeutically enhance killer infiltrated into tumor. These uncover additional molecular how "CD4+ help" regulates persistent have implications toward optimizing generation protective in immunotherapy.

Language: Английский

Citations

526

Clinical implications of T cell exhaustion for cancer immunotherapy DOI
Andrew Chow, Karlo Perica, Christopher A. Klebanoff

et al.

Nature Reviews Clinical Oncology, Journal Year: 2022, Volume and Issue: 19(12), P. 775 - 790

Published: Oct. 10, 2022

Language: Английский

Citations

516